Show simple item record

dc.creatorGray, Andrew Lofts.
dc.creatorAbdool Karim, Salim Safurdeen.
dc.creatorGengiah, Tanuja Narayansamy.
dc.date.accessioned2013-05-07T09:44:49Z
dc.date.available2013-05-07T09:44:49Z
dc.date.created2005
dc.date.issued2005
dc.identifier.citationGray, A.L., Abdool Karim, S.S. & Gengiah, T.N. 2006. Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings. AIDS 20(2) pp. 302-303.en
dc.identifier.issn0269-9370
dc.identifier.urihttp://hdl.handle.net/10413/8835
dc.descriptionCorrespondenceen
dc.description.abstractNo abstract available.en
dc.language.isoenen
dc.publisherLippincott Williams & Wilkins.en
dc.subjectHighly active antiretroviral treatment.en
dc.subjectHIV infections--Treatment.en
dc.subjectTuberculosis--Treatment.en
dc.subject.otherAntiretroviral therapy.en
dc.subject.otherRitonavir/saquinavir.en
dc.subject.otherTuberculosis-HIV co-infected patients.en
dc.subject.otherCo-infection.en
dc.subject.otherHAART.en
dc.titleRitonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings.en
dc.typeOtheren


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record